Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage–SCLC: Results From the Phase 3 MERU Study

Melissa L. Johnson, Zanete Zvirbule, Konstantin Laktionov, Aslaug Helland, Byoung Chul Cho, Vanesa Gutierrez, Benoît Colinet, Herve Lena, Martin Wolf, Maya Gottfried, Isamu Okamoto, Cor van der Leest, Patricia Rich, Jen Yu Hung, Christina Appenzeller, Zhaowen Sun, David Maag, Yan Luo, Caroline Nickner, Alena VajikovaPhilip Komarnitsky, Jair Bar

研究成果: Contribution to journalArticle査読

3 被引用数 (Scopus)

フィンガープリント

「Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage–SCLC: Results From the Phase 3 MERU Study」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

Medicine & Life Sciences